Sun, Feb 1, 2015, 6:29 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Sunesis Pharmaceuticals, Inc. Message Board

  • studythosestocks studythosestocks Sep 11, 2012 8:10 AM Flag

    Significance of announcement

    The Interim analysis proves that there is a statistical significance of vosaroxin and cytar compared to cytar and placebo.
    Apparently not a 90% probability of 40% survival increase but still substantial or they would not have increased the sample size to increase power.
    This should guarantee that we have significant results in 2014 if the roughly 250 added statistically follow the same course.
    Concerns are world market over next year and a half, ongoing financial concerns and delay of another 6-9months before unblinded.
    Positives is that our balance sheet will show a profit of 30 cents this quarter which means nothing to me but will mean something to those institutions and investors who do not successfully dig deep on this one time event.
    We may become a takeover target since the larger companies now know that the odds of success are great and we are the lead candidate for AML with a market cap of less than $150MM.
    Management has put into place their own poison pill to protect them but we are way undervalued for a company with $1Billion potential within 2 1/2 years going to market. All My Opinion.

2.36+0.02(+0.85%)Jan 30 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.